- Display 15 Products per page
Published: June 1, 2007 | Price: $995.00 – $1,990.00
The importance, danger and costs of tuberculosis in the 21st century cannot be understated or underestimated. Though nearly extinct in the 20th century, over 1.6 billion people worldwide suffer from tuberculosis, and it is now presenting a major crisis in public health circles. As illustrated by Kenneth G. Krul, Phd., in Kalorama Information's Global Tuberculosis Strategies, there are abundant opportunities for diagnostic and pharmaceutical companies in combating the global tuberculosis threat. As the author details, there are primarily three focal...Published: June 1, 2007 | Price: $500.00 – $5,990.00
Multiple sclerosis (MS) is a chronic demyelinating CNS disease that causes significant disability in young adults and others. Worldwide, millions of people are affected by multiple sclerosis. Although there is no cure, approved treatments are available to slow the progression of MS and offer improved quality of life. Kalorama Information's: Multiple Sclerosis Treatments: World Market Outlook to 2011 is one of the few publications to take a detailed look at multiple sclerosis treatment market worldwide, as well as treatments that...Published: June 1, 2007 | Price: $1,995.00 – $7,990.00
RFID (Radio Frequency IDentification) technologies are dramatically changing many industries, but as detailed in Kalorama's market research report RFID Opportunities in Healthcare in the U.S., the greatest market for RFID is in healthcare. Hospitals, pharmaceutical companies, nursing homes, and other healthcare entities will benefit from using the technologies to keep track of inventories and patients. What are the best markets within healthcare for RFID? How will benefits outweigh costs? How are these technologies best implemented? Who are the leading providers...Published: July 1, 2007 | Price: $2,500.00 – $5,000.00
An understanding of the market for anesthesia could be worthwhile to any pharmaceutical marketer and any equity company investing or consulting in this area. Anesthesia markets are in one sense simple: growth in these drugs are correlated to prevalence and incidence in disease, and the resulting increase in procedure volumes. But as this market continues to grow, increased competition is steadily escalating in the United States and Europe, which is encouraging more participation in other areas of the world. New...Published: July 1, 2007 | Price: $2,995.00 – $5,990.00
2008 has seen no decrease in attention on wound care products. The aging of the population and a constant demand for products that speed healing and improve outcomes drives the wound care industry. For market watchers, this makes for a dynamic market that has changed in recent years with biological developments. Kalorama Information's analyst Mary Ann Crandall has reviewed the Wound Care Industry in several editions of wound care market reports and has participated in industry panels. Kalorama Information's three-volume...Published: July 1, 2007 | Price: $995.00 – $3,990.00
In light of laboratory pressures to do more with less, laboratory managers transfer cost control onto vendors by means of a constant push for price reductions. In this commercial climate, efficient management of customer and technical service extras is critical. Expertise in managing service offerings will help companies offer service programs that are just enough to differentiate them from the competition. Service programs that offer too much may result in revenue loss. Programs that are perceived to be inadequate place...Published: August 1, 2007 | Price: $2,400.00 – $6,990.00
Abundant opportunities are available for manufacturing companies who enter the outsourcing medical device manufacturing market; but the market is competitive and information has been hard to obtain. Original equipment manufacturers are finding new opportunities with managers located at the corporate headquarters or main manufacturing/assembly operations continually reviewing manufacturing costs and looking to outsourcing for cost efficiency. Kalorama's OEM Contract Manufacturing in Medical Devices Series presents a total study of market for outsourcing in medical devices. It features an exhaustive three-way...Published: August 1, 2007 | Price: $1,995.00 – $3,990.00
The application of nutritional knowledge is an increasingly important part of the management and treatment of disease. Demographics and product development are expected to drive growth in the market for clinical nutrition. This Kalorama Information report - Clinical Nutrition Products: The World Market, represents the second time that Kalorama Information has taken a comprehensive look at the medical nutrition markets in three segments: Infant Nutrition Enteral Nutrition Parenteral Nutrition As part of its comprehensive coverage, this report...Published: August 1, 2007 | Price: $3,995.00 – $7,990.00
The use of virtual reality (VR) technologies in the healthcare field is not simply a far-away future possibility. Technologies are already in place and the benefits from the application of VR are already evident in the healthcare domain. These applications provide doctors an opportunity to perform tasks in a risk-free environment, and make training accessible for a large number of students as the apprenticeship of experienced doctors is not necessary. Additionally, VR simulators allow medical professionals to remain abreast with...Published: August 1, 2007 | Price: $995.00 – $1,990.00
The unrecognized importance, danger and costs of hepatitis in the 21st century cannot be understated or underestimated. The impact of the disease on world society is highly significant and now presenting a major crisis in public health circles. In his exhaustive analysis of the potential diagnosis, screening and therapeutic markets for hepatitis, Ken Krul, PhD. advises companies to think on a global basis. In this study, Global Hepatitis Strategies Krul examines the potential market, epidemiology (hepatitis patient trends) and technology...Published: September 1, 2007 | Price: $1,995.00 – $7,000.00
Orthopedic biomaterial products, which can be organic or synthetic in nature, are implanted into or near a bone fracture to facilitate healing or to compensate for a lack or loss of bone tissue. Biomaterials used in orthopedic surgery include autografts, allografts, xenografts, ceramics, polymers, bone growth factors and synovial fluid substitutes. Among the prominent applications for orthopedic biomaterials are surface coatings for hip prostheses, bone cements, bone defect fillers, and fracture fixation plates. Technological advancement and an aging, active population...Published: September 1, 2007 | Price: $2,995.00 – $5,990.00
2008 has seen no decrease in attention on wound care products. The aging of the population and a constant demand for products that speed healing and improve outcomes drives the wound care industry. For market watchers, this makes for a dynamic market that has changed in recent years with biological developments. Kalorama Information's analyst Mary Ann Crandall has reviewed the Wound Care Industry in several editions of wound care market reports and has participated in industry panels. Kalorama Information's three-volume...Published: September 1, 2007 | Price: $2,995.00 – $5,990.00
2008 has seen no decrease in attention on wound care products. The aging of the population and a constant demand for products that speed healing and improve outcomes drives the wound care industry. For market watchers, this makes for a dynamic market that has changed in recent years with biological developments. Kalorama Information's analyst Mary Ann Crandall has reviewed the Wound Care Industry in several editions of wound care market reports and has participated in industry panels. Kalorama Information's three-volume...Published: October 1, 2007 | Price: $1,995.00 – $6,990.00
Abundant opportunities are available for electronics and advanced systems companies who enter the outsourcing medical device manufacturing market; but the market is competitive and information has been hard to obtain. Contract Manufacturers(CMs) are finding opportunities with managers located at the corporate headquarters or main manufacturing/assembly operations as they take a hard look at costs and seek outsourcing for cost efficiency. Kalorama's OEM Contract Manufacturing in Medical Devices Series presents a total study of market for outsourcing in medical devices. It...Published: October 1, 2007 | Price: $995.00 – $1,990.00
It can be said that pharmaceutical companies face a 'new era.' in the coming years. Old strategies will not produce the same results. A wave of generic competition is poised to affect most brands. Drug companies have had to cut research budgets, leading to a dearth of new products on the market. This means there is very little margin for error in the pricing decision. Drug pricing is one of the key levers that determine the profitability of a drug...